| Malignant disease | |||||
|---|---|---|---|---|---|
| Malignant disease / Antibody responsive malignancy | |||||
| atezolizumab [Specialist drug] | Restricted |
NICE TA525 NICE TA739 NICE TA520 NICE TA584 NICE TA705 NICE TA823 NICE TA638 NICE TA639 NICE TA666 |
|||
| Solution for infusion | |||||
| Tecentriq (Roche Products Ltd) | Restricted | ||||
| avelumab [Specialist drug] | Restricted |
NICE TA517 NICE TA691 NICE TA645 NICE TA788 |
|||
| Solution for infusion | |||||
| Bavencio (Merck Serono Ltd) | Restricted | ||||
| bevacizumab [Specialist drug] | Restricted |
NICE TA118 NICE TA212 NICE TA242 NICE TA178 NICE TA214 NICE TA263 NICE TA284 NICE TA285 NICE TA666 NICE TA946 |
|||
| Solution for infusion | |||||
| Avastin (Roche Products Ltd) | Restricted | ||||
| blinatumomab [Specialist drug] | Restricted |
NICE TA450 NICE TA589 |
|||
| Powder for solution for infusion | |||||
| Blincyto (Amgen Ltd) | Restricted | ||||
| brentuximab vedotin [Specialist drug] | Restricted |
NICE TA478 NICE TA641 NICE TA524 NICE TA577 |
|||
| Powder for solution for infusion | |||||
| Adcetris (Takeda UK Ltd) | Restricted | ||||
| cemiplimab [Specialist drug] | Restricted |
NICE TA802 |
|||
| Solution for infusion | |||||
| Libtayo (Regeneron UK Ltd) | Restricted | ||||
| cetuximab [Specialist drug] | Restricted |
NICE TA145 NICE TA473 NICE TA242 NICE TA439 NICE TA668 |
|||
| Solution for infusion | |||||
| Erbitux (Merck Serono Ltd) | Restricted | ||||
| daratumumab | Restricted |
NICE TA763 NICE TA783 NICE TA897 NICE TA917 |
|||
| Solution for injection | |||||
| Darzalex (Janssen-Cilag Ltd) | Restricted | ||||
| Solution for infusion | |||||
| Darzalex (Janssen-Cilag Ltd) | Restricted | ||||
| dinutuximab beta [Specialist drug] | Named Patient Only |
NICE TA538 |
|||
| Solution for infusion | |||||
| Qarziba (EUSA Pharma (UK) Ltd) | Named Patient Only | ||||
| dostarlimab [Specialist drug] | Restricted |
NICE TA779 |
|||
| durvalumab [Specialist drug] | Restricted |
NICE TA798 NICE TA944 |
|||
| Solution for infusion | |||||
| Imfinzi (AstraZeneca UK Ltd) | Restricted | ||||
| gemtuzumab ozogamicin [Specialist drug] | Restricted |
NICE TA545 |
|||
| Powder for solution for infusion | |||||
| Mylotarg (Pfizer Ltd) | Restricted | ||||
| inotuzumab ozogamicin [Specialist drug] | Restricted |
NICE TA541 |
|||
| Powder for solution for infusion | |||||
| Besponsa (Pfizer Ltd) | Restricted | ||||
| ipilimumab [Specialist drug] | Restricted |
NICE TA268 NICE TA319 NICE TA400 NICE TA716 NICE TA724 NICE TA780 NICE TA818 |
|||
| Solution for infusion | |||||
| Yervoy (Bristol-Myers Squibb Pharmaceuticals Ltd) | Restricted | ||||
| isatuximab [Specialist drug] | Restricted |
NICE TA658 |
|||
| mogamulizumab [Specialist drug] | Restricted |
NICE TA754 NICE TA754 |
|||
| Solution for infusion | |||||
| Poteligeo (Kyowa Kirin Ltd) | Restricted | ||||
| nivolumab [Specialist drug] | Restricted |
NICE TA384 NICE TA400 NICE TA684 NICE TA417 NICE TA780 NICE TA462 NICE TA655 NICE TA713 NICE TA724 NICE TA876 NICE TA530 NICE TA817 NICE TA707 NICE TA746 NICE TA857 NICE TA865 NICE TA716 NICE TA736 NICE TA818 |
|||
| Solution for infusion | |||||
| Opdivo (Bristol-Myers Squibb Pharmaceuticals Ltd) | Restricted | ||||
| obinutuzumab [Specialist drug] | Restricted |
NICE TA343 NICE TA513 NICE TA629 |
|||
| Solution for infusion | |||||
| Gazyvaro (Roche Products Ltd) | Restricted | ||||
| panitumumab [Specialist drug] | Named Patient Only |
NICE TA242 NICE TA439 |
|||
| Solution for infusion | |||||
| Vectibix (Amgen Ltd) | Named Patient Only | ||||
| pembrolizumab [Specialist drug] | Restricted |
NICE TA357 NICE TA366 NICE TA766 NICE TA837 NICE TA428 NICE TA531 NICE TA683 NICE TA770 NICE TA692 NICE TA540 NICE TA540 NICE TA772 NICE TA650 NICE TA830 NICE TA858 NICE TA661 NICE TA709 NICE TA914 NICE TA737 NICE TA801 NICE TA851 NICE TA939 NICE TA904 |
|||
| Solution for infusion | |||||
| Keytruda (Merck Sharp & Dohme (UK) Ltd) | Restricted | ||||
| pertuzumab [Specialist drug] | Restricted |
NICE TA424 NICE TA509 NICE TA569 |
|||
| Solution for infusion | |||||
| Perjeta (Roche Products Ltd) | Restricted | ||||
| pertuzumab with trastuzumab [Specialist drug] | Restricted | ||||
| Solution for injection | |||||
| Phesgo (Roche Products Ltd) | Restricted | ||||
| polatuzumab vedotin [Specialist drug] | Restricted |
NICE TA649 NICE TA874 |
|||
| Powder for solution for infusion | |||||
| Polivy (Roche Products Ltd) | Restricted | ||||
| rituximab | Restricted |
NICE TA308 NICE TA195 NICE TA243 NICE TA137 NICE TA193 NICE TA226 NICE TA174 NICE TA359 NICE TA561 |
|||
| Solution for injection | |||||
| MabThera (Roche Products Ltd) | Named Patient Only | ||||
| Solution for infusion | |||||
| MabThera (Roche Products Ltd) | Named Patient Only | ||||
| Rixathon (Sandoz Ltd) | Restricted | ||||
| sacituzumab govitecan [Specialist drug] | Restricted |
NICE TA819 |
|||
| Powder for solution for infusion | |||||
| Trodelvy (Gilead Sciences Ltd) | Restricted | ||||
| trastuzumab [Specialist drug] | Restricted |
NICE TA34 NICE TA257 NICE TA509 NICE TA208 |
|||
| Solution for injection | |||||
| Herceptin (Roche Products Ltd) | Named Patient Only | ||||
| Powder for solution for infusion | |||||
| Herceptin (Roche Products Ltd) | Named Patient Only | ||||
| Ontruzant (Organon Pharma (UK) Ltd) | Restricted | ||||
| trastuzumab deruxtecan [Specialist drug] | Restricted |
NICE TA704 NICE TA862 |
|||
| Powder for solution for infusion | |||||
| Enhertu (Daiichi Sankyo UK Ltd) | Restricted | ||||
| trastuzumab emtansine [Specialist drug] | Restricted |
NICE TA458 NICE TA632 |
|||
| Powder for solution for infusion | |||||
| Kadcyla (Roche Products Ltd) | Restricted | ||||
| Malignant disease / Immunotherapy responsive malignancy | |||||
| Bacillus Calmette-Guérin [Specialist drug] | On Formulary | ||||
| Powder for reconstitution for instillation | |||||
| OncoTICE (Merck Sharp & Dohme (UK) Ltd) | On Formulary | ||||
| lenalidomide [Specialist drug] | Restricted |
NICE TA322 NICE TA171 NICE TA586 NICE TA587 NICE TA627 NICE TA680 |
|||
| mifamurtide [Specialist drug] | Restricted |
NICE TA235 |
|||
| pomalidomide [Specialist drug] | Restricted |
NICE TA427 |
|||
| talimogene laherparepvec [Specialist drug] | Restricted |
NICE TA410 |
|||
| Solution for injection | |||||
| Imlygic (Amgen Ltd) | Restricted | ||||
| thalidomide [Specialist drug] | Restricted |
NICE TA228 |
|||
| Malignant disease / Targeted therapy responsive malignancy | |||||
| abemaciclib [Specialist drug] | Restricted |
NICE TA563 NICE TA725 NICE TA810 |
|||
| acalabrutinib [Specialist drug] | Restricted |
NICE TA689 NICE TA689 |
|||
| afatinib [Specialist drug] | Restricted |
NICE TA310 |
|||
| alectinib [Specialist drug] | Restricted |
NICE TA536 |
|||
| alpelisib [Specialist drug] | Restricted |
NICE TA816 |
|||
| asciminib [Specialist drug] | Restricted |
NICE TA813 |
|||
| axitinib [Specialist drug] | Restricted |
NICE TA333 NICE TA645 NICE TA650 |
|||
| binimetinib [Specialist drug] | Restricted |
NICE TA562 |
|||
| bortezomib [Specialist drug] | Restricted |
NICE TA370 NICE TA311 NICE TA228 NICE TA129 |
|||
| Solution for injection | |||||
| Bortezomib (Non-proprietary) | Restricted | ||||
| Powder for solution for injection | |||||
| Bortezomib (Non-proprietary) | Restricted | ||||
| Velcade (Janssen-Cilag Ltd) | Restricted | ||||
| bosutinib [Specialist drug] | Restricted |
NICE TA401 |
|||
| brigatinib [Specialist drug] | Restricted |
NICE TA571 NICE TA670 |
|||
| Form unstated | |||||
| Alunbrig (Takeda UK Ltd) | Restricted | ||||
| cabozantinib [Specialist drug] | Restricted |
NICE TA463 NICE TA542 NICE TA516 NICE TA928 NICE TA849 |
|||
| Form unstated | |||||
| Cometriq (Ipsen Ltd) | Restricted | ||||
| carfilzomib [Specialist drug] | Restricted |
NICE TA657 NICE TA695 |
|||
| Powder for solution for infusion | |||||
| Kyprolis (Amgen Ltd) | Restricted | ||||
| ceritinib [Specialist drug] | Restricted |
NICE TA395 NICE TA500 |
|||
| crizotinib [Specialist drug] | Restricted |
NICE TA406 NICE TA422 NICE TA529 |
|||
| dabrafenib [Specialist drug] | Restricted |
NICE TA321 NICE TA396 NICE TA544 NICE TA898 |
|||
| dacomitinib [Specialist drug] | Restricted |
NICE TA595 |
|||
| dasatinib [Specialist drug] | Restricted |
NICE TA426 NICE TA425 |
|||
| encorafenib [Specialist drug] | Restricted |
NICE TA562 NICE TA668 |
|||
| entrectinib [Specialist drug] | Restricted |
NICE TA643 NICE TA644 |
|||
| erlotinib [Specialist drug] | Restricted |
NICE TA227 NICE TA258 NICE TA374 NICE TA374 |
|||
| everolimus | Restricted |
NICE TA421 NICE TA432 NICE TA449 |
|||
|
Afinitor® NICE TA498 Certican® NICE TA348 Certican® NICE TA481 |
|||||
| fedratinib [Specialist drug] | Restricted |
NICE TA756 |
|||
| gefitinib [Specialist drug] | Restricted |
NICE TA192 NICE TA374 |
|||
| gilteritinib [Specialist drug] | Restricted |
NICE TA642 |
|||
| ibrutinib [Specialist drug] | Restricted |
NICE TA429 NICE TA891 NICE TA502 NICE TA795 |
|||
| idelalisib [Specialist drug] | Restricted |
NICE TA359 NICE TA604 |
|||
| imatinib [Specialist drug] | Restricted |
NICE TA326 NICE TA70 NICE TA86 NICE TA209 NICE TA426 NICE TA425 |
|||
| ixazomib [Specialist drug] | Restricted |
NICE TA870 |
|||
| larotrectinib [Specialist drug] | Restricted |
NICE TA630 |
|||
| lenvatinib [Specialist drug] | Restricted |
NICE TA535 NICE TA551 NICE TA498 NICE TA858 NICE TA904 |
|||
| lorlatinib [Specialist drug] | Restricted |
NICE TA628 NICE TA909 |
|||
| midostaurin [Specialist drug] | Restricted |
NICE TA523 NICE TA728 |
|||
| mobocertinib [Specialist drug] | Restricted |
NICE TA855 |
|||
| neratinib [Specialist drug] | Restricted |
NICE TA612 |
|||
| nilotinib [Specialist drug] | Restricted |
NICE TA426 NICE TA425 |
|||
| nintedanib | Restricted |
NICE TA347 NICE TA379 NICE TA864 NICE TA747 |
|||
| niraparib [Specialist drug] | Restricted |
NICE TA673 NICE TA784 |
|||
| olaparib [Specialist drug] | Restricted |
NICE TA598 NICE TA908 NICE TA946 NICE TA886 NICE TA887 NICE TA951 |
|||
| osimertinib [Specialist drug] | Restricted |
NICE TA653 NICE TA654 NICE TA761 |
|||
| palbociclib [Specialist drug] | Restricted |
NICE TA495 NICE TA836 |
|||
| pazopanib [Specialist drug] | Restricted |
NICE TA215 |
|||
| pemigatinib [Specialist drug] | Restricted |
NICE TA722 |
|||
| ponatinib [Specialist drug] | Restricted |
NICE TA451 |
|||
| regorafenib [Specialist drug] | Restricted |
NICE TA488 NICE TA555 NICE TA866 |
|||
| ribociclib [Specialist drug] | Restricted |
NICE TA496 NICE TA687 |
|||
| rucaparib [Specialist drug] | Restricted |
NICE TA611 |
|||
| ruxolitinib [Specialist drug] | Restricted |
NICE TA386 NICE TA921 |
|||
| selpercatinib [Specialist drug] | Restricted |
NICE TA742 NICE TA760 NICE TA911 |
|||
| sorafenib [Specialist drug] | Restricted |
NICE TA178 NICE TA474 NICE TA535 |
|||
| sotorasib [Specialist drug] | Restricted |
NICE TA781 |
|||
| sunitinib [Specialist drug] | Restricted |
NICE TA169 NICE TA179 NICE TA178 NICE TA449 |
|||
| tepotinib [Specialist drug] | Restricted |
NICE TA789 |
|||
| tivozanib [Specialist drug] | Restricted |
NICE TA512 |
|||
| trametinib [Specialist drug] | Restricted |
NICE TA396 NICE TA544 |
|||
| tucatinib [Specialist drug] | Restricted |
NICE TA786 |
|||
| vemurafenib [Specialist drug] | Restricted |
NICE TA269 |
|||
| venetoclax [Specialist drug] | Restricted |
NICE TA561 NICE TA663 NICE TA796 NICE TA765 NICE TA787 |
|||
| zanubrutinib [Specialist drug] | Restricted |
NICE TA833 NICE TA931 |
|||
| Malignant disease / Cytotoxic responsive malignancy | |||||
| arsenic trioxide [Specialist drug] | Restricted |
NICE TA526 |
|||
| Solution for infusion | |||||
| Trisenox (Teva UK Ltd) | Restricted | ||||
| azacitidine [Specialist drug] | Restricted |
NICE TA218 NICE TA399 NICE TA827 |
|||
| Powder for suspension for injection | |||||
| Azacitidine (Non-proprietary) | Restricted | ||||
| Vidaza (Bristol-Myers Squibb Pharmaceuticals Ltd) | Restricted | ||||
| bendamustine hydrochloride [Specialist drug] | Restricted |
NICE TA216 NICE TA472 |
|||
| Powder for solution for infusion | |||||
| Bendamustine hydrochloride (Non-proprietary) | Restricted | ||||
| bleomycin [Specialist drug] | On Formulary | ||||
| busulfan [Specialist drug] | On Formulary | ||||
| cabazitaxel [Specialist drug] | Restricted |
NICE TA391 |
|||
| capecitabine [Specialist drug] | Restricted |
NICE TA263 NICE TA212 NICE TA191 NICE TA61 NICE TA100 |
|||
| carboplatin [Specialist drug] | On Formulary |
NICE TA284 NICE TA285 |
|||
| Solution for infusion | |||||
| Carboplatin (Non-proprietary) | On Formulary | ||||
| carmustine [Specialist drug] | On Formulary |
NICE TA121 |
|||
| chlorambucil [Specialist drug] | On Formulary |
NICE TA343 NICE TA344 |
|||
| chlormethine [Specialist drug] | Named Patient Only |
NICE TA720 |
|||
| cisplatin [Specialist drug] | On Formulary | ||||
| Solution for infusion | |||||
| Cisplatin (Non-proprietary) | On Formulary | ||||
| cladribine | On Formulary |
NICE TA616 |
|||
| Solution for injection | |||||
| Litak (Lipomed GmbH) | On Formulary | ||||
| Solution for infusion | |||||
| Leustat (Atnahs Pharma UK Ltd) | On Formulary | ||||
| cyclophosphamide | On Formulary | ||||
| Powder for solution for injection | |||||
| Cyclophosphamide (Non-proprietary) | On Formulary | ||||
| cytarabine [Specialist drug] | On Formulary | ||||
| Solution for injection | |||||
| Cytarabine (Non-proprietary) | On Formulary | ||||
| dacarbazine [Specialist drug] | On Formulary | ||||
| Powder for solution for injection | |||||
| Dacarbazine (Non-proprietary) | On Formulary | ||||
| daunorubicin [Specialist drug] | On Formulary | ||||
| daunorubicin with cytarabine [Specialist drug] | Restricted |
NICE TA552 |
|||
| Powder for solution for infusion | |||||
| Vyxeos (Jazz Pharmaceuticals UK Ltd) | Restricted | ||||
| docetaxel [Specialist drug] | Restricted |
NICE TA101 NICE TA509 |
|||
| Solution for infusion | |||||
| Docetaxel (Non-proprietary) | Restricted | ||||
| doxorubicin hydrochloride [Specialist drug] | On Formulary |
NICE TA389 NICE TA465 |
|||
| Solution for injection | |||||
| Doxorubicin hydrochloride (Non-proprietary) | On Formulary | ||||
| Solution for infusion | |||||
| Caelyx (Baxter Healthcare Ltd) | On Formulary | ||||
| epirubicin hydrochloride [Specialist drug] | On Formulary | ||||
| Solution for injection | |||||
| Epirubicin hydrochloride (Non-proprietary) | On Formulary | ||||
| eribulin [Specialist drug] | Restricted |
NICE TA423 NICE TA515 |
|||
| Solution for injection | |||||
| Halaven (Eisai Ltd) | Restricted | ||||
| etoposide [Specialist drug] | On Formulary | ||||
| Solution for infusion | |||||
| Etoposide (Non-proprietary) | On Formulary | ||||
| fludarabine phosphate [Specialist drug] | On Formulary |
NICE TA119 NICE TA29 |
|||
| Solution for injection | |||||
| Fludarabine phosphate (Non-proprietary) | On Formulary | ||||
| Powder for solution for injection | |||||
| Fludarabine phosphate (Non-proprietary) | On Formulary | ||||
| fluorouracil | On Formulary | ||||
| Solution for injection | |||||
| Fluorouracil (Non-proprietary) | On Formulary | ||||
| Solution for infusion | |||||
| Fluorouracil (Non-proprietary) | On Formulary | ||||
| gemcitabine [Specialist drug] | Restricted |
NICE TA25 NICE TA116 NICE TA285 NICE TA389 NICE TA476 |
|||
| Solution for infusion | |||||
| Gemcitabine (Non-proprietary) | Restricted | ||||
| hydroxycarbamide | Shared Care | ||||
| idarubicin hydrochloride [Specialist drug] | Named Patient Only | ||||
| ifosfamide [Specialist drug] | On Formulary | ||||
| Powder for solution for injection | |||||
| Ifosfamide (Non-proprietary) | On Formulary | ||||
| irinotecan hydrochloride [Specialist drug] | Restricted |
NICE TA440 |
|||
| Solution for infusion | |||||
| Irinotecan hydrochloride (Non-proprietary) | Restricted | ||||
| Campto (Pfizer Ltd) | Restricted | ||||
| lomustine [Specialist drug] | On Formulary | ||||
| melphalan [Specialist drug] | On Formulary | ||||
| Powder and solvent for solution for injection | |||||
| Melphalan (Non-proprietary) | On Formulary | ||||
| mercaptopurine | On Formulary | ||||
| methotrexate | On Formulary | ||||
| Oral solution | |||||
| Methotrexate (Non-proprietary) | On Formulary | ||||
| Solution for infusion | |||||
| Methotrexate (Non-proprietary) | On Formulary | ||||
| mitomycin [Specialist drug] | On Formulary | ||||
| Powder for solution for injection | |||||
| Mitomycin (Non-proprietary) | On Formulary | ||||
| mitoxantrone [Specialist drug] | On Formulary | ||||
| oxaliplatin [Specialist drug] | Restricted |
NICE TA100 NICE TA93 |
|||
| Solution for infusion | |||||
| Oxaliplatin (Non-proprietary) | Restricted | ||||
| paclitaxel [Specialist drug] | Restricted |
NICE TA55 NICE TA284 NICE TA389 NICE TA476 |
|||
| Solution for infusion | |||||
| Paclitaxel (Non-proprietary) | Restricted | ||||
| panobinostat [Specialist drug] | Restricted |
NICE TA380 |
|||
| pegaspargase [Specialist drug] | Named Patient Only |
NICE TA408 |
|||
| pemetrexed [Specialist drug] | Restricted |
NICE TA124 NICE TA181 NICE TA402 NICE TA190 NICE TA135 |
|||
| Solution for infusion | |||||
| Pemetrexed (Non-proprietary) | Restricted | ||||
| Powder for solution for infusion | |||||
| Pemetrexed (Non-proprietary) | Restricted | ||||
| Alimta (Eli Lilly and Company Ltd) | Restricted | ||||
| pentostatin [Specialist drug] | On Formulary | ||||
| Powder for solution for injection | |||||
| Nipent (Pfizer Ltd) | On Formulary | ||||
| pixantrone [Specialist drug] | Restricted |
NICE TA306 |
|||
| procarbazine [Specialist drug] | On Formulary | ||||
| temozolomide [Specialist drug] | Restricted |
NICE TA23 NICE TA121 |
|||
| topotecan [Specialist drug] | Restricted |
NICE TA183 NICE TA184 NICE TA389 |
|||
| Solution for infusion | |||||
| Topotecan (Non-proprietary) | Restricted | ||||
| trabectedin [Specialist drug] | Restricted |
NICE TA185 NICE TA389 |
|||
| treosulfan [Specialist drug] | On Formulary |
NICE TA640 |
|||
| Powder for solution for injection | |||||
| Treosulfan (Non-proprietary) | On Formulary | ||||
| tretinoin [Specialist drug] | On Formulary | ||||
| trifluridine with tipiracil [Specialist drug] | Restricted |
NICE TA405 NICE TA852 |
|||
| vinblastine sulfate [Specialist drug] | On Formulary | ||||
| Solution for injection | |||||
| Vinblastine sulfate (Non-proprietary) | On Formulary | ||||
| vincristine sulfate [Specialist drug] | On Formulary | ||||
| Solution for injection | |||||
| Vincristine sulfate (Non-proprietary) | On Formulary | ||||
| vinorelbine [Specialist drug] | Restricted | ||||
| Solution for infusion | |||||
| Vinorelbine (Non-proprietary) | Restricted | ||||
| Malignant disease / Cytotoxic drug-induced side effects | |||||
| folinic acid | On Formulary |
NICE TA212 |
|||
| Solution for injection | |||||
| Folinic acid (Non-proprietary) | On Formulary | ||||
| mesna | On Formulary | ||||
| Solution for injection | |||||
| Mesna (Non-proprietary) | On Formulary | ||||
| Malignant disease / Hyperuricaemia associated with cytotoxic drugs | |||||
| allopurinol | On Formulary | ||||
| Malignant disease / Hormone responsive malignancy | |||||
| abiraterone acetate | Restricted |
NICE TA259 NICE TA387 NICE TA721 |
|||
| apalutamide | Restricted |
NICE TA740 NICE TA741 |
|||
| bicalutamide | On Formulary | ||||
| buserelin | On Formulary | ||||
| Solution for injection | |||||
| Suprefact (Neon Healthcare Ltd) | On Formulary | ||||
| cyproterone acetate | On Formulary | ||||
| darolutamide | Restricted |
NICE TA660 NICE TA903 |
|||
| degarelix | Restricted |
NICE TA404 |
|||
| Powder and solvent for solution for injection | |||||
| Firmagon (Ferring Pharmaceuticals Ltd) | Restricted | ||||
| diethylstilbestrol | On Formulary | ||||
| enzalutamide | Restricted |
NICE TA316 NICE TA377 NICE TA580 NICE TA712 |
|||
| flutamide | On Formulary | ||||
| goserelin | On Formulary | ||||
| lanreotide | On Formulary | ||||
| Solution for injection | |||||
| Somatuline Autogel (Ipsen Ltd) | On Formulary | ||||
| medroxyprogesterone acetate | On Formulary | ||||
| megestrol acetate | On Formulary | ||||
| octreotide | On Formulary | ||||
| Solution for injection | |||||
| Octreotide (Non-proprietary) | On Formulary | ||||
| Sandostatin (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
| Powder and solvent for suspension for injection | |||||
| Sandostatin LAR (Novartis Pharmaceuticals UK Ltd) | Restricted | ||||
| Malignant disease / Hormone responsive breast cancer | |||||
| anastrozole | Restricted | ||||
| exemestane | Restricted | ||||
| fulvestrant | Restricted |
NICE TA503 |
|||
| Solution for injection | |||||
| Fulvestrant (Non-proprietary) | Restricted | ||||
| Faslodex (AstraZeneca UK Ltd) | Restricted | ||||
| letrozole | Restricted | ||||
| tamoxifen | On Formulary | ||||
| Oral solution | |||||
| Tamoxifen (Non-proprietary) | On Formulary | ||||
| Malignant disease / Secondary bone metastases and hypercalcaemia | |||||
| calcitonin (salmon) | On Formulary | ||||
| Solution for injection | |||||
| Calcitonin (salmon) (Non-proprietary) | On Formulary | ||||
| denosumab | Restricted |
NICE TA204 NICE TA265 |
|||
| Solution for injection | |||||
| Xgeva (Amgen Ltd) | Restricted | ||||
| ibandronic acid | Shared Care |
NICE TA464 |
|||
| Solution for injection | |||||
| Ibandronic acid (Non-proprietary) | Shared Care | ||||
| Solution for infusion | |||||
| Ibandronic acid (Non-proprietary) | Shared Care | ||||
| Bondronat (Atnahs Pharma UK Ltd) | Shared Care | ||||
| pamidronate disodium | On Formulary | ||||
| Solution for infusion | |||||
| Pamidronate disodium (Non-proprietary) | On Formulary | ||||
| sodium clodronate | On Formulary | ||||
| zoledronic acid | Restricted |
NICE TA464 |
|||
| Infusion | |||||
| Zometa (Phoenix Labs Ltd) | Restricted | ||||
| Solution for infusion | |||||
| Zoledronic acid (Non-proprietary) | Restricted | ||||
| Zometa (Phoenix Labs Ltd) | Restricted | ||||